Parvovirus B19 infections

American Family Physician

Volumn 60, Issue 5, 1999, Pages 1455-1460

  Sabella, Camille ^a   Goldfarb, Johanna ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APLASTIC ANEMIA; ARTHROPATHY; ARTICLE; CLINICAL FEATURE; ERYTHEMA INFECTIOSUM; FETUS DEATH; FETUS HYDROPS; HEMATOLOGIC DISEASE; IMMUNOPATHOLOGY; INFECTION; INTRAUTERINE INFECTION; PARVOVIRUS; VIRUS INFECTION;

ERYTHEMA INFECTIOSUM; FEMALE; HUMANS; HYDROPS FETALIS; JOINT DISEASES; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PROGNOSIS; RED-CELL APLASIA, PURE;

EID: 0032748833     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Cossart YE, Field AM, Cant B, Widdows D. Parvovirus-like particles in human sera. Lancet 1975; 1(7898):72-3.
2. Shneerson JM, Mortimer PP, Vandervelde EM. Febrile illness due to a parvovirus. Br Med J 1980;280:1580.
3. Chorba T, Coccia P, Holman RC, Tattersall P, Anderson LJ, Sudman J, et al. The role of parvovirus B19 in aplastic crisis and erythema infectiosum (fifth disease). J Infect Dis 1986;154:383-93.
4. Finkel TH, Torok TJ, Ferguson PJ, Durigon EL, Zaki SR, Lueng DY, et al. Chronic parvovirus B19 infection and systemic necrotizing vasculitis: opportunistic infection or aetiologic agent? Lancet 1994;343:1255-8.
5. Staud R, Corman LC. Association of parvovirus B19 infections with giant cell arteritis. Clin Infect Dis 1996;22:1123.
6. Nesher G, Osborn TG, Moore TL. Parvovirus infection mimicking systemic lupus erythematosus. Semin Arthritis Rheum 1995;24:297-303.
7. Ozawa K, Kurtzman G, Young N. Replication of the B19 parvovirus in human bone marrow cell cultures. Science 1986;233:883-6.
8. Anderson MJ, Higgins PG, Davis LR, Willman JS, Jones SE, Kidd IM, et al. Experimental parvoviral infection in humans. J Infect Dis 1985;152:257-65.
9. Potter CG, Potter AC, Hatton CS, Chapel HM, Anderson MJ, Pattison JR, et al. Variation of erythroid and myeloid precursors in the marrow and peripheral blood of volunteer subjects infected with human parvovirus (B19). J Clin Invest 1987; 79:1486-92.
10. Cohen BJ, Buckley MM. The prevalence of antibody to human parvovirus B19 in England and Wales. J Med Microbiol 1988;25:151-3.
11. Anderson LJ. Role of parvovirus B19 in human disease. Pediatr Infect Dis J 1987;6:711-8.
12. Koch WC, Adler SP. Human parvovirus B19 infections in women of childbearing age and within families. Pediatr Infect Dis J 1989;8:83-7.
13. Anderson MJ, Cohen BJ. Human parvovirus B19 infections in United Kingdom 1984-86 [Letter]. Lancet 1987;1(8535):738-9.
14. Gillespie SM, Cartter ML, Asch S, Rokos JB, Gary GW, Tsou CJ, et al. Occupational risk of human parvovirus B19 infection for school and day-care personnel during an outbreak of erythema infectiosum. JAMA 1990;263:2061-5.
15. Lyon DJ, Chapman CS, Martin C, Brown KE, Clewley JP, Flower AJ, et al. Symptomatic parvovirus B19 infection and heat-treated factor IX concentrate [Letter]. Lancet 1989;1(8646):1085.
16. Bell LM, Naides SJ, Stoffman P, Hodinka RL, Plotkin SA. Human parvovirus B19 infection among hospital staff members after contact with infected patients. N Engl J Med 1989;321:485-91.
17. Plummer FA, Hammond GW, Forward K, Sekla L, Thompson IM, Jones SE, et al. An erythema infectiosum-like illness caused by human parvovirus infection. N Engl J Med 1985;313:74-9.
18. Woolf AD, Campion GV, Chishick A, Wise S, Cohen BJ, Klouda PT, et al. Clinical manifestations of human parvovirus B19 in adults. Arch Intern Med 1989;149:1153-6.
19. White DG, Woolf AD, Mortimer PP, Cohen BJ, Blake DR, Bacon PA. Human parvovirus arthropathy. Lancet 1985;1(8426):419-22.
20. Nocton JJ, Miller LC, Tucker LB, Schaller JG. Human parvovirus B19-associated arthritis in children. J Pediatr 1993;122:186-90.
21. Young N. Hematologic and hematopoietic consequences of B19 parvovirus infection. Semin Hematol 1988;25:159-72.
22. Serjeant GR, Topley JM, Mason K, Serjeant BE, Pattison JR, Jones SE, et al. Outbreak of aplastic crises in sickle cell anaemia associated with parvovirus-like agent. Lancet 1981;2(8247):595-7.
23. Kurtzman GJ, Ozawa K, Cohen B, Hanson G, Oseas R, Young NS. Chronic bone marrow failure due to persistent B19 parvovirus infection. N Engl J Med 1987;317:287-94.
24. Kurtzman G, Frickhofen N, Kimball J, Jenkins DW, Nienhuis AW, Young NS. Pure red cell aplasia of 10 years' duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy. N Engl J Med 1989;321:519-23.
25. Kinney JS, Anderson LJ, Farrar J, Strikas RA, Kumar ML, Kliegman RM, et al. Risk of adverse outcomes of pregnancy after human parvovirus B19 infection. J Infect Dis 1988;157:663-7.
26. Gratacos E, Torres PJ, Vidal J, Antolin E, Costa J, Jimenez de Anta MT, et al. The incidence of human parvovirus B19 infection during pregnancy and its impact on perinatal outcome. J Infect Dis 1995; 171:1360-3.
27. Silver MM, Hellmann J, Zielenska M, Petric M, Read S. Anemia, blueberry-muffin rash, and hepatomegaly in a newborn infant. J Pediatr 1996;128: 579-86.
28. Fairley CK, Smoleniec JS, Caul OE, Miller E. An observational study of effect of intrauterine transfusions on the outcome of fetal hydrops after parvovirus B19 infection. Lancet 1995;346:1335-7.
29. Parvovirus B19. In: American Academy of Pediatrics. 1997 Red book: report of the Committee on Infectious Diseases. 24th ed. Elk Grove Village, III.: American Academy of Pediatrics; 1997:383-5.